FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135361879> ?p ?o ?g. }

• W3135361879 endingPage "2324" @default.
• W3135361879 startingPage "2312" @default.
• W3135361879 abstract "BackgroundDespite its potential biomechanical advantages, reverse shoulder arthroplasty (RSA) is still considered to be particularly high risk in rheumatoid patients who are osteoporotic and immunodeficient. Our purpose was to report prosthesis survival, complications, and outcomes of RSA in patients with rheumatoid arthritis (RA) at minimum 5-year follow-up.MethodsWe conducted a retrospective multicenter study including 65 consecutive primary RSAs performed in 59 patients with RA between 1991 and 2010. We excluded rheumatoid patients with previous failed anatomic shoulder arthroplasty. Age at surgery averaged 69 years (range, 46-86 years). A structural bone grafting was performed in 18 cases (45%), using the humeral head in 15 cases (BIO-RSA technique), the iliac crest in 2 cases (Norris technique), and an allograft in 1 case. The mean follow-up was 92 months (range, 60-147 months) or until revision surgery.ResultsRevision-free survivorship, using Kaplan-Meier curves, was 96% at 7 years. Two patients had revision surgeries for infections, with associated glenoid loosening in 1 case. No humeral loosening was recorded. The mean adjusted Constant score improved from 36% ± 23% preoperatively to 90% ± 26% postoperatively, and mean Subjective Shoulder Value improved from 21% ± 13% to 85% ± 12%, respectively (P < .001). Active anterior elevation increased from 65° ± 43° to 132° ± 27°, active external rotation increased from 10° ± 26° to 22° ± 27°, and internal rotation improved from buttocks to waist (P < .001). Stable fixation of the baseplate was achieved in all cases (including the 6 patients with end-stage RA), and we did not observe bone graft nonunion or resorption. Preoperative radiologic pattern (centered, ascending, or destructive), presence of acromial fractures or tilt (4 cases, 10%), and scapular notching (55%) on final radiographs were not found to influence outcomes or complication rate. Patients with absent/atrophied teres minor had lower functional results. Overall, 95% of the patients were satisfied with the procedure.ConclusionRSA is a safe and effective procedure for the treatment of RA patients, with a low risk of complications and low rate of revision, regardless of the radiologic presentation and stage of the disease. Rheumatoid patients undergoing primary RSA, with or without glenoid bone grafting, can expect a revision-free survival rate of 96% at 7-year follow-up. RSA offers the benefit of solving 2 key problems encountered in rheumatoid shoulders: glenoid bone destruction and rotator cuff deficiency. Despite its potential biomechanical advantages, reverse shoulder arthroplasty (RSA) is still considered to be particularly high risk in rheumatoid patients who are osteoporotic and immunodeficient. Our purpose was to report prosthesis survival, complications, and outcomes of RSA in patients with rheumatoid arthritis (RA) at minimum 5-year follow-up. We conducted a retrospective multicenter study including 65 consecutive primary RSAs performed in 59 patients with RA between 1991 and 2010. We excluded rheumatoid patients with previous failed anatomic shoulder arthroplasty. Age at surgery averaged 69 years (range, 46-86 years). A structural bone grafting was performed in 18 cases (45%), using the humeral head in 15 cases (BIO-RSA technique), the iliac crest in 2 cases (Norris technique), and an allograft in 1 case. The mean follow-up was 92 months (range, 60-147 months) or until revision surgery. Revision-free survivorship, using Kaplan-Meier curves, was 96% at 7 years. Two patients had revision surgeries for infections, with associated glenoid loosening in 1 case. No humeral loosening was recorded. The mean adjusted Constant score improved from 36% ± 23% preoperatively to 90% ± 26% postoperatively, and mean Subjective Shoulder Value improved from 21% ± 13% to 85% ± 12%, respectively (P < .001). Active anterior elevation increased from 65° ± 43° to 132° ± 27°, active external rotation increased from 10° ± 26° to 22° ± 27°, and internal rotation improved from buttocks to waist (P < .001). Stable fixation of the baseplate was achieved in all cases (including the 6 patients with end-stage RA), and we did not observe bone graft nonunion or resorption. Preoperative radiologic pattern (centered, ascending, or destructive), presence of acromial fractures or tilt (4 cases, 10%), and scapular notching (55%) on final radiographs were not found to influence outcomes or complication rate. Patients with absent/atrophied teres minor had lower functional results. Overall, 95% of the patients were satisfied with the procedure. RSA is a safe and effective procedure for the treatment of RA patients, with a low risk of complications and low rate of revision, regardless of the radiologic presentation and stage of the disease. Rheumatoid patients undergoing primary RSA, with or without glenoid bone grafting, can expect a revision-free survival rate of 96% at 7-year follow-up. RSA offers the benefit of solving 2 key problems encountered in rheumatoid shoulders: glenoid bone destruction and rotator cuff deficiency." @default.
• W3135361879 created "2021-03-15" @default.
• W3135361879 creator A5026379428 @default.
• W3135361879 creator A5029932695 @default.
• W3135361879 creator A5037712172 @default.
• W3135361879 creator A5050092854 @default.
• W3135361879 creator A5054455008 @default.
• W3135361879 creator A5056960926 @default.
• W3135361879 creator A5087173633 @default.
• W3135361879 date "2021-10-01" @default.
• W3135361879 modified "2023-10-12" @default.
• W3135361879 title "Reverse shoulder arthroplasty in rheumatoid arthritis: survival and outcomes" @default.
• W3135361879 cites W1500312458 @default.
• W3135361879 cites W1536810745 @default.
• W3135361879 cites W1839385650 @default.
• W3135361879 cites W1841387130 @default.
• W3135361879 cites W1925445634 @default.
• W3135361879 cites W1938294367 @default.
• W3135361879 cites W1965263359 @default.
• W3135361879 cites W1985152657 @default.
• W3135361879 cites W1986257102 @default.
• W3135361879 cites W1992864110 @default.
• W3135361879 cites W1997043203 @default.
• W3135361879 cites W1999257387 @default.
• W3135361879 cites W2001496935 @default.
• W3135361879 cites W2002541964 @default.
• W3135361879 cites W2007774036 @default.
• W3135361879 cites W2012076124 @default.
• W3135361879 cites W2012227031 @default.
• W3135361879 cites W2012763165 @default.
• W3135361879 cites W2017558903 @default.
• W3135361879 cites W2024277577 @default.
• W3135361879 cites W2032617250 @default.
• W3135361879 cites W2037405274 @default.
• W3135361879 cites W2041438603 @default.
• W3135361879 cites W2052709564 @default.
• W3135361879 cites W2057754322 @default.
• W3135361879 cites W2070506999 @default.
• W3135361879 cites W2071782838 @default.
• W3135361879 cites W2073633067 @default.
• W3135361879 cites W2075593810 @default.
• W3135361879 cites W2077884248 @default.
• W3135361879 cites W2078047809 @default.
• W3135361879 cites W2088549046 @default.
• W3135361879 cites W2093689423 @default.
• W3135361879 cites W2098219674 @default.
• W3135361879 cites W2102963604 @default.
• W3135361879 cites W2108703455 @default.
• W3135361879 cites W2116185534 @default.
• W3135361879 cites W2124927168 @default.
• W3135361879 cites W2145305179 @default.
• W3135361879 cites W2152348310 @default.
• W3135361879 cites W2155768954 @default.
• W3135361879 cites W2164416065 @default.
• W3135361879 cites W2168844069 @default.
• W3135361879 cites W2223262524 @default.
• W3135361879 cites W2273532033 @default.
• W3135361879 cites W2288379008 @default.
• W3135361879 cites W2934615592 @default.
• W3135361879 cites W2966672423 @default.
• W3135361879 cites W2984736499 @default.
• W3135361879 cites W4229715305 @default.
• W3135361879 cites W4245219649 @default.
• W3135361879 cites W4298174367 @default.
• W3135361879 doi "https://doi.org/10.1016/j.jse.2021.01.033" @default.
• W3135361879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33667642" @default.
• W3135361879 hasPublicationYear "2021" @default.
• W3135361879 type Work @default.
• W3135361879 sameAs 3135361879 @default.
• W3135361879 citedByCount "14" @default.
• W3135361879 countsByYear W31353618792021 @default.
• W3135361879 countsByYear W31353618792023 @default.
• W3135361879 crossrefType "journal-article" @default.
• W3135361879 hasAuthorship W3135361879A5026379428 @default.
• W3135361879 hasAuthorship W3135361879A5029932695 @default.
• W3135361879 hasAuthorship W3135361879A5037712172 @default.
• W3135361879 hasAuthorship W3135361879A5050092854 @default.
• W3135361879 hasAuthorship W3135361879A5054455008 @default.
• W3135361879 hasAuthorship W3135361879A5056960926 @default.
• W3135361879 hasAuthorship W3135361879A5087173633 @default.
• W3135361879 hasBestOaLocation W31353618791 @default.
• W3135361879 hasConcept C126322002 @default.
• W3135361879 hasConcept C141071460 @default.
• W3135361879 hasConcept C2777575956 @default.
• W3135361879 hasConcept C2778336525 @default.
• W3135361879 hasConcept C2778715743 @default.
• W3135361879 hasConcept C2779330695 @default.
• W3135361879 hasConcept C2779777117 @default.
• W3135361879 hasConcept C60465272 @default.
• W3135361879 hasConcept C71924100 @default.
• W3135361879 hasConceptScore W3135361879C126322002 @default.
• W3135361879 hasConceptScore W3135361879C141071460 @default.
• W3135361879 hasConceptScore W3135361879C2777575956 @default.
• W3135361879 hasConceptScore W3135361879C2778336525 @default.
• W3135361879 hasConceptScore W3135361879C2778715743 @default.
• W3135361879 hasConceptScore W3135361879C2779330695 @default.
• W3135361879 hasConceptScore W3135361879C2779777117 @default.
• W3135361879 hasConceptScore W3135361879C60465272 @default.

• next